Cite

HARVARD Citation

    Carril-Ajuria, L. et al. (2023). Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status. European journal of cancer. pp. 21-29. [Online]. 
  
Back to record